Categories: Health

EssilorLuxottica completes acquisition of Optegra

EssilorLuxottica completes acquisition of Optegra

Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa.

Under the Optegra, Lexum and Iris brands, Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands.

A natural fit for EssilorLuxottica’s expanding med-tech portfolio, this acquisition represents a significant milestone in the Group’s strategy to enhance eye-health solutions and improve access to the most personalized and seamless patient journey.

The transaction has been cleared by all relevant competition authorities.

GlobeNews Wire

Recent Posts

China takes the lead in all Industry 4.0 technologies, ahead of U.S. and Europe

MHP and LMU Munich publish eighth edition of the Industry 4.0 Barometer China takes the…

15 hours ago

Craft,Confidence,andCreativity:WomenMakersandthePowerBehindtheToAutoCommunity

Shenzhen, March 17, 2026 (GLOBE NEWSWIRE) -- On March 8, International Women’s Day, the ToAuto…

15 hours ago

Lantronix to Showcase Intelligent PoE Infrastructure and Edge AI Solutions for Autonomous Systems at ISC West 2026

IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider…

15 hours ago

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: SAB Biotherapeutics, Inc. MIAMI, March 17, 2026 (GLOBE…

19 hours ago

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: CytomX Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., March…

19 hours ago

Blood Sugar Harmony Liquid Drops Ingredients Disclosed: Complete Details Revealed

Tallmadge, OH, March 17, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This content is for informational purposes…

19 hours ago